All Stories

  1. Nuclear microRNA-466c regulates Vegfa expression in response to hypoxia

    Article • PLoS ONE, March 2022, PLOS

    PhD Mikko P Turunen

  2. Nuclear microRNAs are a fact

    Article • Scientific Reports, July 2019, Springer Science + Business Media

    PhD Mikko P Turunen

  3. Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation

    Article • Human Molecular Genetics, July 2016, Oxford University Press (OUP)

    PhD Mikko P Turunen

  4. Regulation of VEGF-A Expression in Endothelial Cells by Transcriptional Gene Activation or Transcriptional Gene Silencing: Analysis of Genome Wide Transcriptional Response

    Article • Gene Technology, January 2015, OMICS Publishing Group

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  5. Epigenetic Upregulation of Endogenous VEGF-A Reduces Myocardial Infarct Size in Mice

    Article • PLoS ONE, February 2014, PLOS

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  6. A New Gene Therapy Approach for Cardiovascular Disease by Non-coding RNAs Acting in the Nucleus

    Article • Molecular Therapy — Nucleic Acids, January 2014, Elsevier

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  7. Epigenetic regulation in vascular cells

    Article • Current Opinion in Lipidology, October 2013, Wolters Kluwer Health

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  8. Efficient Pro-survival/angiogenic miRNA Delivery by an MRI-Detectable Nanomaterial

    Article • ACS Nano, April 2013, American Chemical Society (ACS)

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  9. Epigenetics and Atherosclerosis

    Article • January 2012, Springer Science + Business Media

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  10. Epigenetic Epidemiology of Atherosclerosis

    Article • November 2011, Springer Science + Business Media

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  11. Epigenetic regulation of key vascular genes and growth factors

    Article • Cardiovascular Research, April 2011, European Society of Cardiology

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  12. Epigenetherapy, a new concept

    Article • BioMolecular Concepts, January 2011, De Gruyter

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  13. Primary effect of 1α,25(OH)2D3 on IL-10 expression in monocytes is short-term down-regulation

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, November 2010, Elsevier

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  14. Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors

    Article • Cardiovascular Research, July 2010, European Society of Cardiology

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  15. Epigenetics and atherosclerosis

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, September 2009, Elsevier

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  16. Expression of urokinase-type plasminogen activator receptor is increased during epileptogenesis in the rat hippocampus

    Article • Neuroscience, September 2009, Elsevier

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  17. Efficient Regulation of VEGF Expression by Promoter-Targeted Lentiviral shRNAs Based on Epigenetic Mechanism: A Novel Example of Epigenetherapy

    Article • Circulation Research, August 2009, Wolters Kluwer Health

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  18. Vascular endothelial growth factor-D transgenic mice show enhanced blood capillary density, improved postischemic muscle regeneration, and increased susceptibility to tumor formation

    Article • Blood, December 2008, American Society of Hematology

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  19. Hypoxia induces microRNA miR-210 in vitro and in vivo

    Article • FEBS Letters, June 2008, Wiley

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  20. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2

    Article • Cardiovascular Research, January 2008, European Society of Cardiology

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  21. New Technologies in Cardiovascular Research: Gene Therapy

    Article • January 2006, Springer Science + Business Media

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  22. Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain

    Article • The Journal of Gene Medicine, January 2006, Wiley

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  23. Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism

    Article • Gene Therapy, March 2005, Nature

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  24. Tissue Inhibitor of Metalloproteinase 1 Adenoviral Gene Therapy Alone Is Equally Effective in Reducing Restenosis as Combination Gene Therapy in a Rabbit Restenosis Model

    Article • Journal of Vascular Research, January 2005, Karger Publishers

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  25. Cardiovascular Gene Therapy

    Article • April 2003, Taylor & Francis

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  26. Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 (KDR/Flk-1) in Ischemic Skeletal Muscle and Its Regeneration

    Article • American Journal Of Pathology, April 2002, Elsevier

    Professor Risto A Kauppinen, PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  27. Combination of VEGF-C gene transfer and treatment with the PDGF receptor kinase inhibitor STI571 leads to persistent reduction in neointima formation in balloon-denunded rabbit aorta

    Article • Journal of the American College of Cardiology, March 2002, Elsevier

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  28. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions

    Article • Vascular Medicine, February 2002, SAGE Publications

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  29. [18] Gene therapy methods in cardiovascular diseases

    Article • January 2002, Elsevier

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  30. Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes

    Article • Gene Therapy, May 2001, Nature

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  31. Optimizedin situ PCR method for the detection of gene transfer vector in histological sections

    Article • The Journal of Gene Medicine, January 2001, Wiley

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  32. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery

    Article • Gene Therapy, September 2000, Nature

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  33. Adventitial ex vivo gene transfer to rabbit carotid artery using autologous vascular smooth muscle cells

    Article • Atherosclerosis, July 2000, Elsevier

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  34. Insights into the molecular pathogenesis of atherosclerosis and therapeutic strategies using gene transfer

    Article • Vascular Medicine, February 2000, SAGE Publications

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  35. Insights into the molecular pathogenesis of atherosclerosis and therapeutic strategies using gene transfer

    Article • Vascular Medicine, February 2000, SAGE Publications

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  36. Gene transfer to placenta

    Article • International Journal of Gynecology & Obstetrics, January 2000, Wiley

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  37. Gene therapy for angiogenesis, restenosis and related diseases

    Article • Experimental Gerontology, August 1999, Elsevier

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  38. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer–plasmid complexes

    Article • Gene Therapy, January 1999, Nature

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  39. QUANTITATIVE DETERMINATION OF GLUTAMATE TURNOVER BY 1 H-OBSERVED, 13 C-EDITED NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY IN THE CEREBRAL CORTEX EX VIVO : INTERRELATIONSHIPS WITH OXYGEN CONSUMPTION

    Article • Neurochemistry International, July 1997, Elsevier

    Professor Risto A Kauppinen, PhD Mikko P Turunen

  40. Local cardiovascular gene therapy

    Article • Taylor & Francis

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala

  41. Gene Deliver y to Rabbit Arteries Using the Collar Model

    Article • Springer Science + Business Media

    PhD Mikko P Turunen, Dr Seppo Yla-Herttuala